What is concerning though is that there is increasing evidence that those with NMSC are twice as likely to develop another type of cancer than the general population.
With such a useful indicator, you’d assume NMSCs are effectively tracked worldwide right? Unfortunately, no. New Zealand, close to Australia’s level of risk is one country failing to do so.
We feel passionately here at Skin Analytics that more effort needs to be put into data collection so that we can get better at finding those with life threatening cancers.
And higher risk includes those who’ve had a NMSC. So we applaud that New Zealand dermatologists are demanding that this information is collected.